Topics

KemPharm Reports Second Quarter 2019 Results

17:09 EDT 13 Aug 2019 | Biotech 365

CELEBRATION, Fla., Aug. 13, 2019 (GLOBE NEWSWIRE) — KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and financial results for the quarter ended June 30, 2019. “Our … Continue reading

Original Article: KemPharm Reports Second Quarter 2019 Results

NEXT ARTICLE

More From BioPortfolio on "KemPharm Reports Second Quarter 2019 Results"

Quick Search